Organization of gynaecological cancer care最新文献

{"title":"1044 Impact of COVID 19 on endometrial cancer follow-up strategies","authors":"A. Amirthanayagam, L. Boulter, H. Morris, T. Miles, H. Manderville, E. Moss","doi":"10.1136/ijgc-2021-esgo.326","DOIUrl":"https://doi.org/10.1136/ijgc-2021-esgo.326","url":null,"abstract":"Introduction/Background∗ The COVID-19 pandemic has had a dramatic impact on many aspects of healthcare, with changes in clinical practice aimed at reducing hospital appointments for patients who are classified as clinically vulnerable. In oncology this has resulted in a move towards the uptake of innovative follow-up schemes, such as patient-initiated or telephone follow-up, in particular for patients who are deemed to be at lower risk of recurrence. The aim of this study was to explore clinician's views of the impact of the COVID19 pandemic on the uptake of such schemes and the challenges in maintaining such schemes in the future. Methodology A mixed methods study was performed consisting of an online questionnaire of clinical nurse specialists and a qualitative interview study of clinicians involved in the follow-up of patients after a diagnosis of endometrial cancer. The interviews were conducted virtually, audio recorded, transcribed verbatim and analysed using framework analysis. Result(s)∗ In total, 22 clinical nurse specialists responded to the survey. Interview participants included gynaecological oncologists, cancer unit gynaecologist, oncologists and clinical nurse specialists. There was universal support to reduce faceto- face consultations during the COVID-19 pandemic and strong support for telephone and patient initiated follow-up. 70% of the participants of the online survey reported that in their opinion COVID-19 pandemic had had an impact on their clinic service by causing accelerated transition to patient initiated or telephone follow-up. The participants also reported patient support for the introduction of virtual follow- up compared to face-to-face appointments. Conclusion∗ The COVID-19 pandemic has resulted in a transition towards telephone and patient initiated follow-up for the follow-up of endometrial cancer. Further research is needed to ensure that these schemes are able to address patients' clinical and information needs if the change from face-to-face clinical follow-up is to be continued following the COVID-19 pandemic.","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115030689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Impact of COVID-19 Pandemic on Gynecological and Breast Cancer Detection Rate: A Tertiary Center Perspective.","authors":"K. Knoll, E. Reiser, K. Leitner, J. Kögl, C. Ebner, C. Marth, I. Tsibulak","doi":"10.21203/RS.3.RS-521354/V1","DOIUrl":"https://doi.org/10.21203/RS.3.RS-521354/V1","url":null,"abstract":"\u0000 Purpose: The aim of the present study was to assess the impact of postponed screening examinations and lockdown measures on gynecological and breast cancer detection rate throughout the year 2020 in a gynecological oncological center in Austria.Methods: Data of 889 patients with either newly diagnosed gynecological or breast cancer between January 2019 and December 2020 were collected. Clinical parameters including symptoms, performance status, comorbidities and referral status were compared in patients, who were newly diagnosed with cancer in the period of the first lockdown from March 2020 – April 2020 and the second lockdown from November 2020 – December 2020 and compared to the same period in 2019.Results: Our results showed a strong decline in newly diagnosed cancers during the lockdown periods: -45% in gynecological cancer and -52% in breast cancer compared to the same period in 2019. Compared to the analogue period of 2019, breast cancer patients reported significantly more tumor-associated symptoms (55% versus 31%, p=0.013) during and in between (48% versus 32%, p=0.022) the lockdowns. During the lockdown periods breast cancer patients were diagnosed with a significantly higher tumor-stage (T2-T4; p=0.047).Conclusion: Both lockdowns led to a strong decrease in newly diagnosed gynecological and breast cancers. Treatment delays in potentially curable disease could lead to inferior clinical outcomes, with the risk of missing the optimal treatment window. As the COVID-19 pandemic will be a challenge for some time to come, new strategies in patient care are needed to optimize cancer screening and management during the pandemic.","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130617983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"331 Testing prediction accuracy of hdu admission following high grade serous advanced ovarian cancer cytoreductive surgery using machine learning methods","authors":"A. Laios, Camilo De lelis Medeiros-De-morais, Y. Tan, G. Saalmink, M. Otify, A. Kaufmann, T. Broadhead, R. Hutson, Kássio Gomes de Lima, G. Theophilou","doi":"10.1136/ijgc-2020-esgo.195","DOIUrl":"https://doi.org/10.1136/ijgc-2020-esgo.195","url":null,"abstract":"331 Figure 1 Abstracts Int J Gynecol Cancer 2020;30(Suppl 4):A1–A142 A111 on M ay 8, 2021 by gest. P rocted by coright. http/ijgc.bm jcom / nt J G ynecol C acer: frst pulished as 10.11ijgc-2020-E S G O .95 on 4 D ecem er 220. D ow nladed fom","PeriodicalId":253349,"journal":{"name":"Organization of gynaecological cancer care","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123916506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}